Doxycycline Hyclate VMD 500 mg/g Powder for Use in Drinking Water for Chickens

Land: Storbritannien

Sprog: engelsk

Kilde: VMD (Veterinary Medicines Directorate)

Aktiv bestanddel:

Doxycycline Hyclate

Tilgængelig fra:

VMD NV

ATC-kode:

QJ01AA02

INN (International Name):

Doxycycline Hyclate

Lægemiddelform:

Powder for use in drinking water

Recept type:

POM-V - Prescription Only Medicine – Veterinarian

Terapeutisk gruppe:

Chickens

Terapeutisk område:

Antimicrobial

Autorisation status:

Authorized

Autorisation dato:

2011-11-29

Produktets egenskaber

Revised: February 2018
AN: 01687/2017
Page 1 of 5
SUMMARY OF PRODUCT CHARACTERISTICS
1.
NAME OF THE VETERINARY MEDICINAL PRODUCT
Doxycycline Hyclate VMD 500 mg/g Powder for Use in Drinking Water for
Chickens
2.
QUALITATIVE AND QUANTITATIVE COMPOSITION
One gram contains:
ACTIVE SUBSTANCE:
Doxycycline hyclate 500 mg
EXCIPIENTS:
For the full list of excipients, see section 6.1.
3.
PHARMACEUTICAL FORM
Powder for use in drinking water
Homogeneous, fine, yellow powder.
4.
CLINICAL PARTICULARS
4.1
TARGET SPECIES
Non-egg laying chickens.
4.2
INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES
Treatment of the following specified infections of the respiratory
tract and alimentary
tract caused by micro-organisms susceptible to doxycycline.
Non-egg laying chickens:
Infections of the respiratory tract caused by _Mycoplasma spp,
Escherichia coli,_
_Avibacterium paragallinarum_ and _Bordetella avium_.
Enteritis caused by _Clostridium perfringens _and_ Clostridium
colinum._
4.3
CONTRAINDICATIONS
Do not use in cases of hypersensitivity to tetracyclines or any of the
excipients.
Do not administer to animals with severe liver or kidney
insufficiency.
4.4
SPECIAL WARNINGS FOR EACH TARGET SPECIES
None.
4.5
SPECIAL PRECAUTIONS FOR USE
Special precautions for use in animals
Due to variability (time, geographical) in susceptibility of bacteria
to doxycycline,
bacteriological sampling and susceptibility testing of micro-organisms
from diseased
animals on farm are highly recommended.
A high resistance rate of _E.coli_ isolated from chickens, against
tetracyclines has been
documented. Therefore the product should be used for the treatment of
infections
caused by _E.coli_ only after susceptibility testing has been carried
out.
Revised: February 2018
AN: 01687/2017
Page 2 of 5
As eradication of the target pathogen may not be achieved, medication
should
therefore be combined with good management practices e.g. good
hygiene, proper
ventilation, no overstocking.
Special precautions to be taken by the person administering the
veterinary medicina